Figure S3 from CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer
Year: 2026
Type: other
Abstract: GSEA analysis of cell lines with and without RMC-7977 + erlotinib synergy.
Authors: Szu-Aun Long, Haley Todd, Grace Goodhart, Wen-Hsuan Chang, Amber M. Amparo, Rachel Bridgens, Julien Dilly, Se Jun Park, Robert M. Beal, Sara M. Shehadeh, Megan A. Satyadi, Vidushi K. Trivedi, Sarah E. Ackermann, Raivath Mukherjee, Craig M. Goodwin, A. Cole Edwards, Clint A. Stalnecker, Kenneth D. Greis, Andrew J. Aguirre, G. Aaron Hobbs, Kirsten L. Bryant, Syed A. Ahmad, Adrienne D. Cox, Channing J. Der, Andrew M. Waters
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7130540968
Cites:
Cited by:
Related to: